Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KOD Kodiak Sciences Inc.

休市中 10-02 16:00:00 EDT

94.45

-4.01

-4.07%

盘后94.77

+0.32+0.33%

19:59 EDT

最高98.95	最低88.63	成交量267.65万
今开98.95	昨收98.46	日振幅10.48%
总市值59.11亿	流通市值37.48亿	总股本6,258万
成交额2.48亿	换手率6.74%	流通股本3,969万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KOD","market":"US","secType":"STK","nameCN":"Kodiak Sciences Inc.","latestPrice":94.45,"timestamp":1790971200000,"preClose":98.46,"halted":0,"volume":2676503,"hourTrading":{"tag":"盘后","latestPrice":94.7653,"preClose":94.45,"latestTime":"19:59 EDT","volume":20080,"amount":1894825.1816,"timestamp":1790985542823,"change":0.3153,"changeRate":0.003338,"amplitude":0.018159},"delay":0,"changeRate":-0.040727198862482134,"floatShares":39686400,"shares":62578441,"eps":-4.157111,"marketStatus":"休市中","change":-4.01,"latestTime":"10-02 16:00:00 EDT","open":98.95,"high":98.95,"low":88.6303,"amount":248273355.05605,"amplitude":0.104811,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.157111,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":98.46,"preHourTrading":{"tag":"盘前","latestPrice":98.15,"preClose":98.46,"latestTime":"09:29 EDT","volume":14799,"amount":1469274.76197,"timestamp":1790947799999,"change":-0.31,"changeRate":-0.003148,"amplitude":0.019285},"postHourTrading":{"tag":"盘后","latestPrice":94.7653,"preClose":94.45,"latestTime":"19:59 EDT","volume":20080,"amount":1894825.1816,"timestamp":1790985542823,"change":0.3153,"changeRate":0.003338,"amplitude":0.018159},"volumeRatio":0.24073087339961796,"impliedVol":0.8362,"impliedVolPercentile":0.1394},"requestUrl":"/m/hq/s/KOD/wiki","defaultTab":"wiki","newsList":[{"id":"1124084461","title":"异动解读｜Kodiak Sciences盘中下跌5.08%，报93.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124084461","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124084461?lang=zh_cn&edition=full","pubTime":"2026-10-02 22:01","pubTimestamp":1790949663,"startTime":"0","endTime":"0","summary":"10月2日，Kodiak Sciences盘中下跌5.08%，报93.46美元/股，成交额3080.33万美元。Kodiak Sciences所在的生物科技行业中，个股中，Moderna涨0.13%，吉利德科学跌0.74%，艾伯维公司涨0.29%，安进跌0.31%，Natera涨0.24%。Kodiak Sciences Inc.是一家临床阶段的生物制药公司，专门研究治疗慢性高流行性视网膜疾病的新疗法，其最先进的候选产品使用公司抗体生物聚合物偶联平台构建，旨在维持眼组织中有效的药物水平。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118556380","title":"异动解读｜Kodiak Sciences盘中上涨6.9%，大股东Baker Brothers大幅增持逾35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1118556380","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118556380?lang=zh_cn&edition=full","pubTime":"2026-10-01 21:34","pubTimestamp":1790861684,"startTime":"0","endTime":"0","summary":"10月1日，Kodiak Sciences盘中上涨6.9%，报101.48美元/股，成交额2186.25万美元。消息面上，公司董事兼10%以上股东Felix J. Baker与Julian C. Baker通过旗下基金667, L.P.及Baker Brothers Life Sciences LP，于9月28日至29日在二级市场多次买入公司普通股，累计增持约35.9万股，成交均价区间约84至90美元，交易完成后两只基金合计持股约2019万股，进一步巩固大股东地位。此外，Felix J. Baker还另有多笔交易累计增持超86万股，价格区间覆盖60.50至86.47美元。公司计划于第四季度向监管机构提交相关数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak大涨，大股东增持释放利好","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183108251","title":"Form 4 | Kodiak Sciences 股东兼董事 Baker Felix 与 Baker Julian 通过旗下基金合计增持约359,000股普通股（P）","url":"https://stock-news.laohu8.com/highlight/detail?id=1183108251","media":"公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183108251?lang=zh_cn&edition=full","pubTime":"2026-10-01 04:35","pubTimestamp":1790800516,"startTime":"0","endTime":"0","summary":"根据最新提交的Form 4，Felix J. Baker 与 Julian C. Baker 作为 Kodiak Sciences Inc.的董事及10%股东，通过旗下基金 667, L.P. 与 Baker Brothers Life Sciences LP 于2026年9月28日至29日多次在二级市场买入公司普通股，单笔交易数量从数百股至近20万股不等，成交均价区间约在84至90美元，累计增持约35.9万股。交易完成后，两只基金合计持股约2,019万股，进一步巩固其大股东地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146381561","title":"Kodiak Sciences Inc.董事 Felix J. Baker 增持227671股","url":"https://stock-news.laohu8.com/highlight/detail?id=1146381561","media":"公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146381561?lang=zh_cn&edition=full","pubTime":"2026-10-01 04:35","pubTimestamp":1790800516,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc.董事 Felix J. Baker 于2026年9月28日通过多项交易累计购入227,671股普通股。每股交易价格在79.07美元至86.47美元之间。Felix J. Baker是一位已知的活跃投资者，本次大规模增持可能表明他对公司未来前景的信心，并对市场起到积极的信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122019945","title":"Kodiak Sciences Inc.董事Felix J. Baker增持639,386股","url":"https://stock-news.laohu8.com/highlight/detail?id=1122019945","media":"公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122019945?lang=zh_cn&edition=full","pubTime":"2026-10-01 04:30","pubTimestamp":1790800217,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc.董事Felix J. Baker于2026年9月28日通过多个交易共计增持了639,386股普通股。这些交易价格范围从60.50美元到78.91美元不等。随着持股比例的增加，此次增持可能表明该公司受到管理层的看好，这对市场可能是一个积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak Sciences Inc.董事Felix J. Baker增持639,386股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103201498","title":"异动解读｜Kodiak Sciences盘中上涨6.48%，III期临床积极数据持续提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1103201498","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103201498?lang=zh_cn&edition=full","pubTime":"2026-09-30 21:34","pubTimestamp":1790775275,"startTime":"0","endTime":"0","summary":"9月30日，Kodiak Sciences盘中上涨6.48%，报96.805美元/股，成交额5448.19万美元。消息面上，公司此前宣布旗下两款实验性眼科药物Zenkuda及tabirafusp-ted在湿性年龄相关性黄斑变性III期临床试验中均达到主要终点，两项治疗在第一年视力改善方面均实现对阿柏西普的非劣效性，且54%的患者在第一年内维持了六个月的给药间隔。公司计划于第四季度向监管机构提交Zenkuda在五项III期研究中的数据，覆盖湿性黄斑变性、糖尿病视网膜病变及视网膜静脉阻塞后黄斑水肿等适应症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kodiak Sciences盘中上涨，III期临床数据持续提振","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114345070","title":"异动解读｜Kodiak Sciences夜盘下跌7.83%，报82.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114345070","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114345070?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:09","pubTimestamp":1790644145,"startTime":"0","endTime":"0","summary":"9月29日，Kodiak Sciences夜盘下跌7.83%，报82.88美元/股，成交额45.17万美元。Kodiak Sciences所在的生物科技行业中，个股中，Moderna跌0.81%，安进涨0%，艾伯维公司涨0%，再生元制药公司涨0%，吉利德科学涨0%。Kodiak Sciences是一家临床阶段的生物制药公司，专门研究治疗慢性高流行性视网膜疾病的新疗法，其最先进的候选产品使用公司抗体生物聚合物偶联平台构建，旨在维持眼组织中有效的药物水平。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196770946","title":"异动解读｜Kodiak Sciences盘中上涨146.43%，两款眼科药物III期试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1196770946","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196770946?lang=zh_cn&edition=full","pubTime":"2026-09-28 23:02","pubTimestamp":1790607753,"startTime":"0","endTime":"0","summary":"9月28日，Kodiak Sciences盘中上涨146.43%，报79.72美元/股，成交额15.7亿美元。消息面上，公司宣布旗下两款实验性眼科药物Zenkuda及tabirafusp-ted在湿性年龄相关性黄斑变性III期临床试验中均达到主要终点，两项治疗在第一年视力改善方面均实现对阿柏西普的非劣效性，且54%的患者在第一年内维持了六个月的给药间隔。公司计划于第四季度向监管机构提交Zenkuda在五项III期研究中的数据，覆盖湿性黄斑变性、糖尿病视网膜病变及视网膜静脉阻塞后黄斑水肿等适应症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Kodiak Sciences盘中大涨，眼科新药III期试验成功","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165743631","title":"Kodiak Sciences第二季度净亏损6564.3万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165743631","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165743631?lang=zh_cn&edition=full","pubTime":"2026-08-14 04:14","pubTimestamp":1786652083,"startTime":"0","endTime":"0","summary":"8月13日，Kodiak Sciences Inc. 公布第二季度财报，营收表现不佳，净亏损达到6564.3万美元。与此同时，该公司每股基本收益为-1.05美元，这一数据低于市场预期。财报显示，公司在本季度面临不小的财务压力，投资者需密切关注其后续业绩走向。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124423666","title":"Kodiak Sciences宣布：全球III期ALTO试验启动，Ksi-501首例糖尿病黄斑水肿患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1124423666","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124423666?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:45","pubTimestamp":1786394724,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc.今日正式对外宣告，其全球范围的III期ALTO临床试验已成功招募首例患者。此项研究旨在评估Ksi-501在糖尿病黄斑水肿患者群体中的疗效与安全性。这一里程碑式的进展，标志着针对这一常见致盲性眼病的潜在治疗手段，迈入了关键性的验证阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KOD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146556468","title":"Kodiak Sciences完成首项三期PEAK队列入组；顶线数据预计2026年12月公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1146556468","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146556468?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:01","pubTimestamp":1786014085,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc.（KOD）——这家生物科技公司已顺利完成其首项三期PEAK临床试验的受试者入组工作。根据公司公告，顶线数据预计将在2026年12月对外披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KOD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222565","title":"Kodiak Sciences Inc盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518222565?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:38","pubTimestamp":1741613884,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时38分，Kodiak Sciences Inc股票出现波动，股价急速跳水5.52%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为471.88%、72.73%、52.37%，振幅较大的相关个股有Seer, Inc.、Scisparc Ltd.、Trevi Therapeutics, Inc.，振幅分别为98.72%、34.57%、25.35%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021380498a29e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021380498a29e60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166732","title":"Kodiak Sciences Inc盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517166732?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:36","pubTimestamp":1741271765,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时36分，Kodiak Sciences Inc股票出现异动，股价大幅下挫5.15%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1027.16%、163.48%、52.81%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为24.20%、23.83%、23.12%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223605989eb541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223605989eb541&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948874","title":"Kodiak Sciences Inc盘中异动 大幅拉升5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517948874?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185063,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Kodiak Sciences Inc股票出现波动，股价大幅上涨5.82%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为311.23%、251.30%、184.03%，振幅较大的相关个股有Aditxt, Inc.、4D Molecular Therapeutics, Inc.、Creative Medical Technology Holdings, Inc.，振幅分别为10.04%、8.56%、8.18%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103abe9b064&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103abe9b064&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516608059","title":"Kodiak Sciences Inc盘中异动 大幅下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516608059?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:20","pubTimestamp":1741101607,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时20分，Kodiak Sciences Inc股票出现波动，股价快速跳水5.13%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1171.96%、1133.58%、682.84%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为66.03%、66.02%、64.44%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232007989bb9d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232007989bb9d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516300652","title":"Kodiak Sciences Inc盘中异动 快速跳水5.11%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516300652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:27","pubTimestamp":1741026436,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时27分，Kodiak Sciences Inc股票出现波动，股价快速下挫5.11%。截至发稿，该股报3.90美元/股，成交量9.8082万股，换手率0.19%，振幅9.61%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.10%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022717989a456a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022717989a456a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516374488","title":"Kodiak Sciences Inc盘中异动 临近午盘股价大涨5.24%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516374488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516374488?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:45","pubTimestamp":1740761128,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时45分，Kodiak Sciences Inc股票出现异动，股价快速拉升5.24%。截至发稿，该股报4.22美元/股，成交量6.3753万股，换手率0.12%，振幅6.36%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.31%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100452896343872&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100452896343872&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514861629","title":"Kodiak Sciences Inc盘中异动 急速拉升5.21%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514861629?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:20","pubTimestamp":1740597602,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时20分，Kodiak Sciences Inc股票出现波动，股价大幅上涨5.21%。截至发稿，该股报4.04美元/股，成交量32.7705万股，换手率0.62%，振幅7.03%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.60%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270320029893deb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270320029893deb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015318","title":"Kodiak Sciences Inc盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514015318?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:12","pubTimestamp":1740496323,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时12分，Kodiak Sciences Inc股票出现波动，股价急速下挫5.20%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1040.92%、583.07%、532.48%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Gri Bio, Inc.、Silexion Therapeutics Corp，振幅分别为58.82%、56.51%、43.83%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523120398925613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523120398925613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513205087","title":"Kodiak Sciences Inc盘中异动 早盘急速下跌5.17%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513205087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513205087?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:06","pubTimestamp":1740409561,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时06分，Kodiak Sciences Inc股票出现波动，股价急速下跌5.17%。截至发稿，该股报4.22美元/股，成交量1.8913万股，换手率0.04%，振幅5.89%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.45%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230601962ea188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230601962ea188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kodiak.com;ir.kodiak.com","stockEarnings":[{"period":"1week","weight":1.9196},{"period":"1month","weight":1.5187},{"period":"3month","weight":1.4507},{"period":"6month","weight":1.3246},{"period":"1year","weight":6.0328},{"period":"ytd","weight":2.378}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kodiak Sciences Inc.于2009年6月22日以Oligasis LLC的名义成立为有限责任公司。2015年9月8日更名并在特拉华州注册成立公司。该公司是一家临床阶段的生物制药公司，专门研究治疗慢性高流行性视网膜疾病的新疗法。Kodiak Sciences Inc.最先进的候选产品是KSI-301，这是一种使用公司抗体生物聚合物偶联平台（ABC Platform）构建的生物疗法，旨在维持眼组织中有效且有效的药物水平。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.076525},{"month":2,"riseRate":0.5,"avgChangeRate":-0.093763},{"month":3,"riseRate":0.125,"avgChangeRate":-0.076889},{"month":4,"riseRate":0.625,"avgChangeRate":0.017136},{"month":5,"riseRate":0.5,"avgChangeRate":0.047406},{"month":6,"riseRate":0.75,"avgChangeRate":0.031274},{"month":7,"riseRate":0.625,"avgChangeRate":0.076709},{"month":8,"riseRate":0.5,"avgChangeRate":0.003695},{"month":9,"riseRate":0.75,"avgChangeRate":0.304064},{"month":10,"riseRate":0.625,"avgChangeRate":0.185811},{"month":11,"riseRate":0.75,"avgChangeRate":0.296496},{"month":12,"riseRate":0.625,"avgChangeRate":0.266402}],"exchange":"NASDAQ","name":"Kodiak Sciences Inc.","nameEN":"Kodiak Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kodiak Sciences Inc.,KOD,Kodiak Sciences Inc.股票,Kodiak Sciences Inc.股票老虎,Kodiak Sciences Inc.股票老虎国际,Kodiak Sciences Inc.行情,Kodiak Sciences Inc.股票行情,Kodiak Sciences Inc.股价,Kodiak Sciences Inc.股市,Kodiak Sciences Inc.股票价格,Kodiak Sciences Inc.股票交易,Kodiak Sciences Inc.股票购买,Kodiak Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}